Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation

Projections of Global Mortality and Burden of Disease from 2002 to 2030

Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386 · see citing works

ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.

Monod, J., Wyman, J., & Changeux, J. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80285-6 · Cited by 7,681 · see citing works

Neural systems of reinforcement for drug addiction: from actions to habits to compulsion

Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785 · see citing works

Treating tobacco use and dependence-Clinical practice guideline

Mc, F. (2000) · Medical Entomology and Zoology · Cited by 3,616 · see citing works

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Jorenby, D. E. (2006) · JAMA · doi:10.1001/jama.296.1.56 · Cited by 1,635 · see citing works

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Gonzales, D. (2006) · JAMA · doi:10.1001/jama.296.1.47 · Cited by 1,361 · see citing works

Antidepressants for smoking cessation

Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352 · see citing works

Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine

Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.

Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073 · see citing works

Nicotine replacement therapy for smoking cessation

Silagy, C., Lancaster, T., Stead, L., Mant, D., & Fowler, G. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub2 · Cited by 972 · see citing works

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930 · see citing works

Nicotine receptor partial agonists for smoking cessation

Hey, K., Lancaster, T., & Bala, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103 · Cited by 864 · see citing works

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area

Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740 · see citing works

Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum

Benowitz, N. L., Porchet, H., Sheiner, L., & Jacob, P. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.107 · Cited by 619 · see citing works

Nicotine maintains robust self-administration in rats on a limited-access schedule

Corrigall, W. A., & Coen, K. M. (1989) · Psychopharmacology · doi:10.1007/bf00589894 · Cited by 578 · see citing works

Antidepressants for smoking cessation

Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567 · see citing works

Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors

Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566 · cited 1× · see citing works

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533 · see citing works

Bupropion is a nicotinic antagonist

Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509 · see citing works

Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice

Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 505 · see citing works

The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour

Laviolette, S. R., & van der Kooy, D. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1298 · Cited by 452 · see citing works

On the application of “a plausible model” of allosteric proteins to the receptor for acetylcholine

Karlin, A. (1967) · Journal of Theoretical Biology · doi:10.1016/0022-5193(67)90011-2 · Cited by 433 · see citing works

Nicotine addiction and comorbidity with alcohol abuse and mental illness

Dani, J. A., & Harris, R. A. (2005) · Nature Neuroscience · doi:10.1038/nn1580 · Cited by 382 · see citing works

Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine

Fenster, C. P., Rains, M. F., Noerager, B., Quick, M. W., & Lester, R. A. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05747.1997 · Cited by 332 · see citing works

Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities

HUGHES, J. R., HIGGINS, S. T., & BICKEL, W. K. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03744.x · Cited by 312 · see citing works

Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement

Chaudhri, N., Caggiula, A. R., Donny, E. C., Palmatier, M. I., Liu, X., & Sved, A. F. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0178-1 · Cited by 271 · see citing works

Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit

Papke, R. L., & Heinemann, S. F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09896-7 · Cited by 259 · see citing works

Nicotine addiction: the possible role of functional upregulation

Buisson, B., & Bertrand, D. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01979-9 · Cited by 254 · see citing works

The neurobiology of tobacco dependence: A preclinical perspective on the role of the dopamine projections to the nucleus

Balfour, D. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200412331324965 · Cited by 251 · see citing works

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

Rose, J. E., Behm, F. M., Westman, E. C., Levin, E. D., STEIN, R. M., & Ripka, G. V. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.105 · Cited by 248 · see citing works

Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors

Marubio, L. M., Gardier, A. M., Durier, S., David, D., Klink, R., Arroyo‐Jimenez, M. M., McIntosh, J. M., Rossi, F., Champtiaux, N., Zoli, M., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02564.x · Cited by 242 · see citing works

Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition

Shoaib, M., Schindler, C. W., & Goldberg, S. R. (1997) · Psychopharmacology · doi:10.1007/s002130050159 · Cited by 233 · see citing works

Regulation of Nicotinic Acetylcholine Receptor Numbers and Function by Chronic Nicotine Exposure

Gentry, C., & Lukas, R. (2002) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007023339184 · Cited by 232 · see citing works

Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic Receptors

Damaj, M. I., Carroll, F. I., Eaton, J. B., Navarro, H. A., Blough, B. E., Mirza, S., Lukas, R. J., & Martin, B. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001313 · Cited by 212 · see citing works

Nicotinic modulation of neuronal networks: from receptors to cognition

Mansvelder, H. D., van Aerde, K. I., Couey, J. J., & Brussaard, A. B. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0070-z · Cited by 201 · see citing works

METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO

Obach, R. S., Reed‐Hagen, A. E., Krueger, S. S., Obach, B. J., O’Connell, T. N., Zandi, K. S., Miller, S., & Coe, J. W. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006767 · Cited by 199 · see citing works

Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction

Pidoplichko, V. I., Noguchi, J., Areola, O. O., Liang, Y., Peterson, J., Zhang, T., & Dani, J. A. (2004) · Learning & Memory · doi:10.1101/lm.70004 · Cited by 196 · see citing works

The neurobiology of tobacco addiction

Stolerman, I. P., & Shoaib, M. C. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90638-9 · Cited by 195 · see citing works

Cytisine for Smoking Cessation

Etter, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1553 · Cited by 195 · see citing works

Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.

Rose, J. E., Behm, F. M., & Westman, E. C. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.6.3.331 · Cited by 159 · see citing works

Nicotine replacement therapy in smoking cessation

Campbell, I. (2003) · Thorax · doi:10.1136/thorax.58.6.464 · Cited by 153 · see citing works

Untitled work

(1999) · doi:10.1016/s0376-8716(99)00025-3 · Cited by 146 · see citing works

Nicotine–mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.

Rose, J. E., Behm, F. M., & Westman, E. C. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.6.3.331 · Cited by 146 · see citing works

WHO Framework Convention on Tobacco Control: a global "good" for public health.

Taylor, A. L., & Bettcher, D. W. (2000) · PubMed · Cited by 125 · see citing works

The clinical significance of ‘small’ effects of smoking cessation treatments

WEST, R. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01750.x · Cited by 124 · see citing works

SSR591813, a Novel Selective and Partial α4β2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

Cohen, C., Bergis, O. E., Galli, F., Lochead, A. W., Jegham, S., Biton, B., Léonardon, J., Avenet, P., Sgard, F., Besnard, F., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049262 · Cited by 114 · see citing works

Nicotine is Highly Effective at Producing Desensitization of Rat α4β2 Neuronal Nicotinic Receptors

Paradiso, K. G., & Steinbach, J. H. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.053447 · Cited by 100 · see citing works

Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans

Foll, B. L., & Goldberg, S. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.005 · Cited by 98 · see citing works

Neuropharmacology and potential efficacy of new treatments for tobacco dependence

Fagerström, K. O., & Balfour, D. J. K. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.2.107 · Cited by 95 · see citing works

Extinguishing the rewarding value of smoke cues: Pharmacological and behavioral treatments

Rose, J., & Behm, F. M. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001696501 · Cited by 94 · see citing works

Multiple‐Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

Faessel, H. M., Gibbs, M. A., Clark, D. J., Rohrbacher, K. D., Stolar, M. J., & Burstein, A. H. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006292624 · Cited by 93 · see citing works

Mecamylamine (a nicotine antagonist) for smoking cessation

Lancaster, T., & Stead, L. F. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001009 · Cited by 89 · see citing works

Mecamylamine increases nicotine preference and attenuates nicotine discrimination

Rose, J. E., Sampson, A. P., Levin, E. D., & Henningfield, J. E. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90061-0 · Cited by 79 · see citing works

Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion

Cryan, J. F., Gasparini, F., Heeke, G. V., & Markou, A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02890-3 · Cited by 76 · see citing works

3,5-Bicyclic aryl piperidines: A novel class of α4β2 neuronal nicotinic receptor partial agonists for smoking cessation

Coe, J. W., Brooks, P. R., Wirtz, M. C., Bashore, C. G., Bianco, K. E., Vetelino, M. G., Arnold, E. P., Lebel, L. A., Fox, C. B., Tingley, F. D., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.035 · Cited by 73 · see citing works

In pursuit of α4β2 nicotinic receptor partial agonists for smoking cessation: Carbon analogs of (−)-cytisine

Coe, J. W., Vetelino, M. G., Bashore, C. G., Wirtz, M. C., Brooks, P. R., Arnold, E. P., Lebel, L. A., Fox, C. B., Sands, S. B., Davis, T. I., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.036 · Cited by 69 · see citing works

New treatments for smoking cessation

Hughes, J. R. (2000) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.3.143 · Cited by 68 · see citing works

Nicotine addiction: insights from recent animal studies

Mathieu-Kia, A.-M., Kellogg, S. H., Butelman, E. R., & Kreek, M. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1096-0 · Cited by 62 · see citing works

Pharmacologic basis and treatment of cigarette smoking.

Henningfield, J. E. (1984) · PubMed · Cited by 56 · see citing works

Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine

Mansbach, R. S., Chambers, L. K., & Rovetti, C. C. (2000) · Psychopharmacology · doi:10.1007/s002130050047 · Cited by 50 · see citing works

Non-Nicotine Pharmacotherapy for Smoking Cessation

Benowitz, N. L., & Peng, M. W. (2000) · CNS Drugs · doi:10.2165/00023210-200013040-00004 · Cited by 46 · see citing works

Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence

Rose, J. E., & Levin, E. D. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90086-u · Cited by 40 · see citing works

Synthesis and pharmacological activity of 2,3,4,5-tetrahydro-1,5-methano-1H-3-benzazepines

Mazzocchi, P. H., & Stahly, B. C. (1979) · Journal of Medicinal Chemistry · doi:10.1021/jm00190a020 · Cited by 21 · see citing works

Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system

Taly, A., Corringer, P., Guédin, D., Lestage, P. J., & Changeux, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 706 · see citing works

Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior

Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 636 · see citing works

Clinical Pharmacology of Nicotine: Implications for Understanding, Preventing, and Treating Tobacco Addiction

Benowitz, N. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.3 · Cited by 515 · see citing works

Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

Steensland, P., Simms, J. A., Holgate, J. Y., Richards, J. K., & Bartlett, S. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705368104 · Cited by 368 · see citing works

Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models

Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328 · see citing works

Varenicline improves mood and cognition during smoking abstinence

Patterson, F., Jepson, C., Strasser, A. A., Loughead, J., Perkins, K. A., Gur, R. C., Frey, J. M., Siegel, S., & Lerman, C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.028 · Cited by 222 · see citing works

Current advances in research in treatment and recovery: Nicotine addiction

Prochaska, J. J., & Benowitz, N. L. (2019) · Science Advances · doi:10.1126/sciadv.aay9763 · Cited by 219 · see citing works

Maternal tobacco smoking, nicotine replacement and neurobehavioural development

Pauly, J. R., & Slotkin, T. A. (2008) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00852.x · Cited by 214 · see citing works

Pharmacologic mechanisms of crystal meth

Kish, S. J. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071675 · Cited by 208 · see citing works

α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease

Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 194 · see citing works

Tobacco addiction and the dysregulation of brain stress systems

Bruijnzeel, A. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.015 · Cited by 172 · see citing works

Addressing tobacco use disorder in smokers in early remission from alcohol dependence: The case for integrating smoking cessation services in substance use disorder treatment programs

Kalman, D., Kim, S. Y., DiGirolamo, G. J., Smelson, D. A., & Ziedonis, D. M. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.08.009 · Cited by 165 · see citing works

How Can We Use Our Knowledge of Alcohol-Tobacco Interactions to Reduce Alcohol Use?

McKee, S. A., & Weinberger, A. H. (2012) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185549 · Cited by 160 · see citing works

Pre‐clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

Rollema, H., Shrikhande, A., Ward, K., Tingley III, F., Coe, J., O'Neill, B., Tseng, E., Wang, E., Mather, R., Hurst, R., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00682.x · Cited by 162 · see citing works

Effects of Varenicline on Smoking Cue–Triggered Neural and Craving Responses

Franklin, T. R., Wang, Z., Suh, J. J., Hazan, R., Cruz, J., Li, Y., Goldman, M., Detre, J. A., O’Brien, C. P., & Childress, A. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.190 · Cited by 162 · see citing works

The 5-HT2C Receptor Agonist Lorcaserin Reduces Nicotine Self-Administration, Discrimination, and Reinstatement: Relationship to Feeding Behavior and Impulse Control

Higgins, G. A., Silenieks, L. B., Rossmann, A., Rizos, Z., Noble, K., Soko, A. D., & Fletcher, P. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.303 · Cited by 151 · see citing works

Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression

Anthenelli, R. M., Morris, C. D., Ramey, T. S., Dubrava, S., Tsilkos, K., Russ, C., & Yunis, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00005 · Cited by 136 · see citing works

Down-Regulation of Amygdala and Insula Functional Circuits by Varenicline and Nicotine in Abstinent Cigarette Smokers

Sutherland, M. T., Carroll, A. J., Salmeron, B. J., Ross, T. J., Hong, L. E., & Stein, E. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.035 · Cited by 131 · see citing works

A preliminary investigation of varenicline for heavy drinking smokers

Fucito, L. M., Toll, B. A., Wu, R., Romano, D. M., Tek, E., & O’Malley, S. S. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2160-9 · Cited by 124 · see citing works

A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation

Faessel, H. M., Obach, R. S., Rollema, H., Ravva, P., Williams, K. E., & Burstein, A. H. (2010) · Clinical Pharmacokinetics · doi:10.2165/11537850-000000000-00000 · Cited by 120 · see citing works

The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats

O’Connor, E. C., Parker, D., Rollema, H., & Mead, A. N. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1739-5 · Cited by 118 · see citing works

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3

Zesiewicz, T. A., Greenstein, P. E., Sullivan, K. L., Wecker, L., Miller, A., Jahan, I., Chen, R., & Perlman, S. (2012) · Neurology · doi:10.1212/wnl.0b013e318247cc7a · Cited by 119 · see citing works

Molecules and circuits involved in nicotine addiction: The many faces of smoking

Picciotto, M. R., & Mineur, Y. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.028 · Cited by 117 · see citing works

Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis

McKee, S. A., Smith, P. H., Kaufman, M., Mazure, C. M., & Weinberger, A. H. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv207 · Cited by 119 · see citing works

Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

Rollema, H., Hajós, M., Seymour, P. A., Kozak, R., Majchrzak, M. J., Guanowsky, V., Horner, W. E., Chapin, D. S., Hoffmann, W. E., Johnson, D. E., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.033 · Cited by 117 · see citing works

Effects of Varenicline on Abstinence and Smoking Reward Following a Programmed Lapse

McClure, E. A., Vandrey, R. G., Johnson, M. W., & Stitzer, M. L. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts101 · Cited by 112 · see citing works

Allosteric modulation of nicotinic acetylcholine receptors

Chatzidaki, A., & Millar, N. S. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.028 · Cited by 104 · see citing works

Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice

Kamens, H. M., Andersen, J., & Picciotto, M. R. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1759-1 · Cited by 100 · see citing works

Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders

Bacher, I., Wu, B., Shytle, D. R., & George, T. P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903329102 · Cited by 96 · see citing works

Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal

De Biasi, M., & Salas, R. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-355 · Cited by 95 · see citing works

Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders

Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 94 · see citing works

Pharmacotherapy for Alcohol Use Disorder

Swift, R. M., & Aston, E. R. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000079 · Cited by 92 · see citing works

Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking

O’Malley, S. S., Zweben, A., Fucito, L. M., Wu, R., Piepmeier, M. E., Ockert, D. M., Bold, K. W., Petrakis, I. L., Muvvala, S. B., Jatlow, P. I., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3544 · Cited by 94 · see citing works

Discovery and development of varenicline for smoking cessation

Jordan, C. J., & Xi, Z. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1458090 · Cited by 90 · see citing works

Parallel Anxiolytic-Like Effects and Upregulation of Neuronal Nicotinic Acetylcholine Receptors Following Chronic Nicotine and Varenicline

Turner, J. R., Castellano, L. M., & Blendy, J. A. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq206 · Cited by 78 · see citing works

Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats

LeSage, M. G., Shelley, D., Ross, J. T., Carroll, F. I., & Corrigall, W. A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.08.024 · Cited by 78 · see citing works

A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation

McKee, S. A., Potenza, M. N., Kober, H., Sofuoglu, M., Arnsten, A. F., Picciotto, M. R., Weinberger, A. H., Ashare, R., & Sinha, R. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114562091 · Cited by 75 · see citing works

Cytisine and cytisine derivatives. More than smoking cessation aids

Gotti, C., & Clementi, F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105700 · Cited by 77 · see citing works

Varenicline in the treatment of tobacco dependence

Fagerström, K. O. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s927 · Cited by 77 · see citing works

Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats

Huang, L. Z., Campos, C., Ly, J., Carroll, F. I., & Quik, M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.032 · Cited by 73 · see citing works

Cigarette smoking during pregnancy regulates the expression of specific nicotinic acetylcholine receptor (nAChR) subunits in the human placenta

Machaalani, R., Ghazavi, E., Hinton, T., Waters, K. A., & Hennessy, A. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.02.015 · Cited by 72 · see citing works

Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum

Bordia, T., Hrachova, M., Chin, M., McIntosh, J. M., & Quik, M. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194852 · Cited by 70 · see citing works

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations

Ebbert, J. O. (2010) · Patient Preference and Adherence · doi:10.2147/ppa.s10620 · Cited by 67 · see citing works

Dual dopamine/serotonin releasers: Potential treatment agents for stimulant addiction.

Rothman, R. B., Blough, B. E., & Baumann, M. H. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0014103 · Cited by 67 · see citing works

Quinoxaline: A comprehension of current pharmacological advancement in medicinal chemistry

Suthar, S. K., Chundawat, N. S., Singh, G. P., Padrón, J. M., & Jhala, Y. K. (2022) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2022.100040 · Cited by 66 · see citing works

Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: A novel use of the odour span task

Rushforth, S. L., Allison, C., Wonnacott, S., & Shoaib, M. C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.022 · Cited by 65 · see citing works

The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review

Crunelle, C. L., Miller, M. L., Booij, J., & van den Brink, W. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.001 · Cited by 63 · see citing works

Role for the nicotinic cholinergic system in movement disorders; therapeutic implications

Quik, M., Zhang, D., Perez, X. A., & Bordia, T. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.05.004 · Cited by 62 · see citing works

Nicotine reduces established levodopa‐induced dyskinesias in a monkey model of Parkinson's disease

Quik, M., Mallela, A., Ly, J., & Zhang, D. (2013) · Movement Disorders · doi:10.1002/mds.25594 · Cited by 60 · see citing works

Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats

Biała, G., Staniak, N., & Budzyńska, B. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0498-5 · Cited by 61 · see citing works

Serotonin receptors as potential targets for modulation of nicotine use and dependence

Fletcher, P. J., LE, A., & Higgins, G. A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00918-7 · Cited by 61 · see citing works

Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort

Franklin, T. R., Wang, Z., Li, Y., Suh, J. J., Goldman, M., Lohoff, F. W., Cruz, J., Hazan, R., Jens, W., Detre, J. A., et al. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00277.x · Cited by 59 · see citing works

Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of α4β2 nicotinic receptors in rats

Spiller, K., Xi, Z.-X., Li, X., Ashby, C. R., Callahan, P. M., Tehim, A., & Gardner, E. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.04.006 · Cited by 58 · see citing works

Evaluation of chemically diverse 5-HT2C receptor agonists on behaviours motivated by food and nicotine and on side effect profiles

Higgins, G. A., Silenieks, L. B., Lau, W., de Lannoy, I. A. M., Lee, D. K. H., Izhakova, J., Coen, K. M., Lê, A. D., & Fletcher, P. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2919-2 · Cited by 57 · see citing works

Nicotinic receptor modulation to treat alcohol and drug dependence

Rahman, S., Engleman, E. A., & Bell, R. L. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00426 · Cited by 58 · see citing works

Novel Pharmacological Approaches for Treating Tobacco Dependence and Withdrawal

Buchhalter, A. R., Fant, R. V., & Henningfield, J. E. (2008) · Drugs · doi:10.2165/00003495-200868080-00005 · Cited by 57 · see citing works

Nicotinic receptor-based therapeutics and candidates for smoking cessation

Dwoskin, L. P., Smith, A. M., Wooters, T. E., Zhang, Z., Crooks, P. A., & Bardo, M. T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.002 · Cited by 56 · see citing works

Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration

George, O., Lloyd, A., Carroll, F. I., Damaj, M. I., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2024-3 · Cited by 52 · see citing works

Targeting α4β2 Nicotinic Acetylcholine Receptors in Central Nervous System Disorders: Perspectives on Positive Allosteric Modulation as a Therapeutic Approach

Grupe, M., Grunnet, M., Bastlund, J. F., & Jensen, A. A. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12361 · Cited by 54 · see citing works

Prescriber's Guide

Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275 · Cited by 51 · see citing works

α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties

Mineur, Y. S., Einstein, E. B., Seymour, P. A., Coe, J. W., O'Neill, B. T., Rollema, H., & Picciotto, M. R. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328347546d · Cited by 49 · see citing works

Multiple CNS nicotinic receptors mediate l-dopa-induced dyskinesias: Studies with parkinsonian nicotinic receptor knockout mice

Quik, M., Campos, C., & Grady, S. R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.027 · Cited by 49 · see citing works

Nicotinic Receptor Agonists Reduce l-DOPA–Induced Dyskinesias in a Monkey Model of Parkinson's Disease

Zhang, D., Mallela, A., Sohn, D., Carroll, F. I., Bencherif, M., Letchworth, S. R., & Quik, M. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.207639 · Cited by 49 · see citing works

Persistent Genital Arousal Disorder: A Case Report in a Woman with Lifelong PGAD Where Serendipitous Administration of Varenicline Tartrate Resulted in Symptomatic Improvement

Korda, J. B., Pfaus, J. G., & Goldstein, I. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01210.x · Cited by 47 · see citing works

Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia

Wecker, L., Engberg, M. E., Philpot, R. M., Lambert, C. S., Kang, C. W., Antilla, J. C., Bickford, P. C., Hudson, C. E., Zesiewicz, T. A., & Rowell, P. P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.016 · Cited by 46 · see citing works

Addiction: the clinical interface

Nutt, D., & Lingford-Hughes, A. R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.101 · Cited by 45 · see citing works

Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial

Lesage, E., Aronson, S., Sutherland, M., Ross, T., Salmeron, B., & Stein, E. (2017) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2017.0400 · Cited by 48 · see citing works

Dopamine/serotonin releasers as medications for stimulant addictions

Rothman, R. B., Blough, B. E., & Baumann, M. H. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00919-9 · Cited by 42 · see citing works

Plasticity of Addiction: A Mesolimbic Dopamine Short‐Circuit?

Niehaus, J. L., Cruz‐Bermúdez, N. D., & Kauer, J. A. (2009) · The American Journal on Addictions · doi:10.1080/10550490902925946 · Cited by 42 · see citing works

Mechanism-based medication development for the treatment of nicotine dependence

Xi, Z., Spiller, K. J., & Gardner, E. L. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.46 · Cited by 42 · see citing works

Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence

Ebbert, J. O., Burke, M. V., & Hays, J. T. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s83469 · Cited by 42 · see citing works

Neuropharmacology of the Interoceptive Stimulus Properties of Nicotine

Wooters, T. E., Bevins, R. A., & Bardo, M. T. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902030243 · Cited by 40 · see citing works

Effect of the α4β2∗ nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in β2 knock-out mice with selective re-expression of the β2 subunit in the ventral tegmental area

Repérant, C., Pons, S., Dufour, E., Rollema, H., Gardier, A. M., & Maskos, U. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.10.007 · Cited by 41 · see citing works

Unlocking Nicotinic Selectivity via Direct C‒H Functionalization of (−)-Cytisine

Campello, H. R., del Villar, S. G., Honraedt, A., Minguez, T., Oliveira, A. S. F., Ranaghan, K. E., Shoemark, D. K., Bermúdez, I., Gotti, C., Sessions, R. B., et al. (2018) · Chem · doi:10.1016/j.chempr.2018.05.007 · Cited by 39 · see citing works

From antipsychotic to anti-schizophrenia drugs: role of animal models

Geyer, M. A., Olivier, B., Joëls, M., & Kahn, R. S. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.06.006 · Cited by 39 · see citing works

An open-label pilot trial ofN-acetylcysteine and varenicline in adult cigarette smokers

McClure, E. A., Baker, N. L., Gipson, C. D., Carpenter, M. J., Roper, A. P., Froeliger, B., Kalivas, P. W., & Gray, K. M. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2014.933839 · Cited by 38 · see citing works

Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice

Gulick, D., & Gould, T. J. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.03.002 · Cited by 37 · see citing works

ACh signaling modulates activity of the GABAergic signaling network in the basolateral amygdala and behavior in stress-relevant paradigms

Mineur, Y. S., Mose, T. N., Maibom, K. L., Pittenger, S. T., Soares, A. R., Wu, H., Taylor, S. R., Huang, Y., & Picciotto, M. R. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01749-7 · Cited by 36 · see citing works

The Nicotinic Acetylcholine Receptor Partial Agonist Varenicline Increases the Ataxic and Sedative‐Hypnotic Effects of Acute Ethanol Administration in C57BL/6J Mice

Kamens, H. M., Andersen, J., & Picciotto, M. R. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01301.x · Cited by 37 · see citing works

The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data

Rollema, H., & Hurst, R. S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4921-9 · Cited by 38 · see citing works

CC 4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation

Sala, M., Braida, D., Pucci, L., Manfredi, I., Marks, M. J., Wageman, C. R., Grady, S. R., Loi, B., Fucile, S., Fasoli, F., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02204.x · Cited by 36 · see citing works

Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats

Sotomayor‐Zárate, R., Gysling, K., Busto, U. E., Cassels, B. K., Tampier, L., & Quintanilla, M. E. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2974-3 · Cited by 36 · see citing works

The Necessity of α4* Nicotinic Receptors in Nicotine-Driven Behaviors: Dissociation Between Reinforcing and Motor Effects of Nicotine

Cahir, E., Pillidge, K., Drago, J., & Lawrence, A. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.35 · Cited by 36 · see citing works

Differential α4(+)/(−)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms

Lucero, L. M., Weltzin, M. M., Eaton, J. B., Cooper, J. F., Lindstrom, J. M., Lukas, R. J., & Whiteaker, P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.684373 · Cited by 35 · see citing works

Chemistry and Behavioral Studies Identify Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile

Zhang, H., Tückmantel, W., Eaton, J. B., Yuen, P., Yu, L.-F., Bajjuri, K. M., Fedolak, A., Wang, D., Ghavami, A., Caldarone, B. J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201157c · Cited by 34 · see citing works

The Role of Mesoaccumbens Dopamine in Nicotine Dependence

Balfour, D. J. K. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_3 · Cited by 34 · see citing works

86Rb+ efflux mediated by α4β2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization

Marks, M. J., Meinerz, N. M., Brown, R. W. B., & Collins, A. C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.040 · Cited by 33 · see citing works

The language barrier and institutional provincialism in science

Stolerman, I. P., & Stenius, K. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.07.010 · Cited by 33 · see citing works

Structural and Rate Studies of the Formation of Substituted Benzynes

Riggs, J. C., Ramı́rez, A., Cremeens, M. E., Bashore, C. G., Candler, J., Wirtz, M. C., Coe, J. W., & Collum, D. B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0754655 · Cited by 32 · see citing works

Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans

Sofuoglu, M., Herman, A. I., Mooney, M. E., & Waters, A. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1643-z · Cited by 32 · see citing works

Varenicline Dose Dependently Enhances Responding for Nonpharmacological Reinforcers and Attenuates the Reinforcement-Enhancing Effects of Nicotine

Levin, M. E., Weaver, M. T., Palmatier, M. I., Caggiula, A. R., Sved, A. F., & Donny, E. C. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr213 · Cited by 31 · see citing works

Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial

McRae‐Clark, A. L., Gray, K. M., Baker, N. L., Sherman, B. J., Squeglia, L. M., Sahlem, G. L., Wagner, A. M., & Tomko, R. L. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109111 · Cited by 30 · see citing works

Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure–Activity Relationship and Preclinical Characterization

Sinha, N., Karche, N. P., Verma, M. K., Walunj, S. S., Nigade, P. B., Jana, G., Kurhade, S. P., Hajare, A. K., Tilekar, A. R., Jadhav, G. R., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01569 · Cited by 30 · see citing works

Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice

Kruk-Słomka, M., Budzyńska, B., & Biała, G. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70904-0 · Cited by 28 · see citing works

Cognitive effects of labeled addictolytic medications

Pujol, C., Paasche, C., Laprévote, V., Trojak, B., Vidailhet, P., Bacon, É., & Lalanne, L. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.008 · Cited by 28 · see citing works

Effects of Chronic Varenicline Treatment on Nicotine, Cocaine, and Concurrent Nicotine+Cocaine Self-Administration

Mello, N. K., Fivel, P. A., Kohut, S. J., & Carroll, F. I. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.325 · Cited by 26 · see citing works

Rhodiola rosea L. extract and its active compound salidroside antagonized both induction and reinstatement of nicotine place preference in mice

Titomanlio, F., Perfumi, M. C., & Mattioli, L. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3351-y · Cited by 27 · see citing works

The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice

de Moura, F. B., & McMahon, L. R. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4514-4 · Cited by 28 · see citing works

Resisting the Urge to Smoke and Craving during a Smoking Quit Attempt on Varenicline: Results from a Pilot FMRI Study

Hartwell, K. J., LeMatty, T., McRae‐Clark, A. L., Gray, K. M., George, M. S., & Brady, K. T. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2012.750665 · Cited by 26 · see citing works

The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine

Paterson, N. E. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832c7083 · Cited by 27 · see citing works

Partial nicotinic acetylcholine (α4β2) agonists as promising new medications for smoking cessation

Budhiraja, S., & Singh, J. (2008) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.44150 · Cited by 6 · see citing works

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533 · see citing works

Nicotine Addiction and Alpha4beta2* Nicotinic Acetylcholine Receptors

Maurer, J. J., & Schmidt, H. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00031-9 · Cited by 1 · see citing works

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930 · see citing works

The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data

Rollema, H., & Hurst, R. S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4921-9 · Cited by 38 · see citing works